Empagliflozin-Loaded Floating Density-Modulated Drug Delivery System as a Novel Approach for Sustained Therapy in Type 2 Diabetes Mellitus with Sodium-Glucose Co-Transporter-2 Inhibition . CDF [Internet]. 2025 Feb. 19 [cited 2025 Oct. 12];54(3):4357-68. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/1801